Published in

Elsevier, Urologic Oncology: Seminars and Original Investigations, 6(38), p. 606-607, 2020

DOI: 10.1016/j.urolonc.2020.03.027

Elsevier, Urologic Oncology: Seminars and Original Investigations, 5(38), p. 433-439, 2020

DOI: 10.1016/j.urolonc.2020.01.002

Links

Tools

Export citation

Search in Google Scholar

A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non–muscle-invasive bladder cancer

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO